发明名称 1,2,4-TRIAZOLONE DERIVATIVE-CONTAINING MEDICINE
摘要 PROBLEM TO BE SOLVED: To provide a new therapeutic or prophylactic agent for disorders such as: mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington chorea, eating disorder, hypertension, digestive disorder, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head trauma, inflammation, immune-related disorder, alopecia, etc.SOLUTION: A therapeutic or prophylactic agent for disorders such as: mood disorder, anxiety disorder, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington chorea, eating disorder, hypertension, digestive disorder, drug dependence, epilepsy, cerebral infarction, cerebral ischemia, cerebral edema, head trauma, inflammation, immune-related disorder, alopecia, etc., contains as an effective ingredient, 1,2,4-triazolone derivative expressed by general formula (1A) or pharmaceutically permissive salts thereof having arginine-vasopressin 1b receptor antagonistic action.
申请公布号 JP2013227299(A) 申请公布日期 2013.11.07
申请号 JP20130068344 申请日期 2013.03.28
申请人 TAISHO PHARMACEUTICAL CO LTD 发明人 KUWATA TSUYOSHI;YOSHINAGA MITSUKANE;ISHIZAKA TOMOKO;WAKASUGI DAISUKE;SHIROKAWA SHINICHI;HATTORI NOBUTAKA;SHIMAZAKI YOICHI;MIYAKOSHI NAOKI
分类号 A61K31/4196;A61K31/4439;A61K31/454;A61K31/4545;A61K31/46;A61K31/4725;A61K31/496;A61K31/5377;A61K31/5386;A61K31/541;A61K31/553;A61P1/00;A61P3/04;A61P9/10;A61P9/12;A61P17/02;A61P17/14;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/22;A61P25/28;A61P25/30;A61P29/00;A61P37/00;A61P43/00;C07D249/12;C07D401/04;C07D401/10;C07D403/04;C07D403/10;C07D405/12;C07D413/10;C07D413/14;C07D451/02;C07D491/10;C07D491/107;C07D498/08 主分类号 A61K31/4196
代理机构 代理人
主权项
地址